Adverse drug reaction patterns of anti-retroviral drugs: A study in a tertiary care teaching Institute of north east India

CHRISTINA ZOSANGPUII; SWAGATA DATTA; NGANGOM GUNINDRO; DN MEENA; SURJIT SINGH NAMEIRAKPAM

doi:10.22159/ajpcr.2022.v15i4.44174

Authors

CHRISTINA ZOSANGPUII Department of Pharmacology, Regional Institute of Medical Sciences, Imphal, Manipur, India. https://orcid.org/0000-0001-6302-1165
SWAGATA DATTA Department of Pharmacology, Regional Institute of Medical Sciences, Imphal, Manipur, India.
NGANGOM GUNINDRO Department of Pharmacology, Regional Institute of Medical Sciences, Imphal, Manipur, India.
DN MEENA Department of Pharmacology, Regional Institute of Medical Sciences, Imphal, Manipur, India.
SURJIT SINGH NAMEIRAKPAM Pharmacovigilance Centre, Regional Institute of Medical Sciences, Imphal, Manipur, India.

DOI:

https://doi.org/10.22159/ajpcr.2022.v15i4.44174

Keywords:

Adverse drug reactions, Pharmacovigilance, World Health Organization-Uppsala Monitoring Centre criteria, Anti-retroviral therapy

Abstract

Objective: The use of antiretroviral drugs is associated with significant safety concerns but there is still insufficient data about the toxicity profile of ART drugs especially in developing countries. Hence, this study was done to describe the severity and pattern of different types of adverse drug reactions that occurs with antiretroviral therapy.
Method: A retrospective cross-sectional study was done at Pharmacovigilance centre RIMS utilizing data from January 2016 till December 2019.
Result: A total of 190 cases reported during the study period were included in this study. Incidence was higher in females (109) as compared to males (81). The most common regimen responsible was TLE (69.5%) followed by ZLN (16.3%). Involvement of dermatological system (27.4%) was most common. The most common ADR associated with TLE was skin rash (28.3%) which was less severe as compared to the most common ADR associated with ZLN, which was anaemia (40.6%). On evaluation of WHO-UMC causality of ADRs, majority were found to be possible (78.2%).
Conclusion: TLE regimen requires special focus as it was the most common regimen causing ADR but patients on ZLN regimen need to be closely monitored as they were found to cause more serious ADRs. A more active pharmacovigilance is needed for better understanding of toxicities related to ART.
Key words: Adverse drug reactions, Pharmacovigilance, WHO-UMC criteria, Anti-retroviral therapy.

Downloads

Download data is not yet available.

References

Reddy TM, Prasad DP, Reddy SG, Dudu S, Mohan R, Punnamaraju KP, et al. A pharmacovigilance study of antiretroviral therapy in HIV positive out patients at a tertiary care teaching hospital. Int J Basic Clin Pharmacol 2018;7:2419-23. doi: 10.18203/2319-2003. ijbcp2018485

Behera SK, Rath B, Biswal SB, Mohapatra S. Pattern of adverse drug reactions in a tertiary care hospital in Western Odisha. Int J Pharm Sci Res 2018;9:2471-7.

Bansal R, Daryani KK, Singh AP. Pharmacovigilance study of antiretroviral therapy in human immunodeficiency virus/acquired immunodeficiency syndrome patients at antiretroviral therapy centre, Jabalpur. Asian J Pharm Clin Res 2018;11:272-9. doi: 10.22159/ ajpcr.2018.v11i9.26747

Singh A, Chouhan O, Gehlot A, Tandi GP, Dua M. The study of adverse drug reactions (ADRS) of antiretroviral therapy (ART) on HIV infected persons (PLHIV) at our ART centre, Jodhpur, Rajasthan. Sch J App Med Sci 2016;4:696-703.

Oumar AA, Abdoulaye A, Maiga M, Sidibe Y, Cissoko Y, Konate I, et al. Adverse drug reactions to antiretroviral therapy (ART): Prospective study in HIV infected adults in Sikasso (Mali). J Pharmacovigilance 2017;5:228. doi: 10.4172/2329-6887.1000228

Alvi Y, Khalique N, Ahmad A, Sameen S. A critical assessment of rationality in drug promotion literature using WHO guidelines. J Pharmacovigilance Drug Saf 2019;16:22-5.

Pharmacovigilance for Antiretrovirals in Resource-poor Countries. World Health Organisation; 2007. Available from: http://wwww.who. int/medicine/publications/PhV_for_antiretrovirals.pdf?ua=1. [Last accessed on 2021 Aug 18].

National Technical Guidelines on Antiretroviral Treatment National AIDS Control Organisation. India: NACO; 2018.

Agu KA, Oparah AC. Adverse drug reactions to antiretroviral therapy: Results from spontaneous reporting system in Nigeria. Perspect Clin Res 2013;4:117-24. doi: 10.4103/2229-3485.111784, PMID 23833736

Pharmacovigilance programme of India (PvPI). Ghaziabad: Indian Pharmacopoeia Commission; 2019. Internet Home Page. Available from: http://www.ipc.gov.in/PvPI/adr.html. [Last accessed on 2021 Sep 10].

Causality Assessment of Suspected Adverse Reactions. World Health Organization; 2019. Available from: https://www.who.umc.org/ Graphics/24734. [Last accessed on 2021 Jun 08].

Chauhan NS, Shah SP, Desai MK, Shah A. A safety analysis of different drug regimens used in human immunodeficiency virus-positive patients. Indian J Sex Transm Dis AIDS 2018;39:84-90. doi: 10.4103/ ijstd.IJSTD_116_17, PMID 30623177

Rukmangathen R, Brahmanapalli VD, Thammisetty DP, Pemmasani D, Gali SD, Atmakuru RB. Study of adverse drug reactions to antiretroviral therapy in a tertiary care hospital, Tirupati. Perspect Clin Res 2020;11:158-63. doi: 10.4103/picr.PICR_133_18, PMID 33489833

Patil PT, Pawar MP, Halasawadekar NR, Shinde MP, Kumbhar AV, Rathod MS. Current pattern of adverse drug reactions to anti-retroviral therapy in an antiretroviral therapy centre attached to a government medical college of Maharashtra, India: A retrospective study. Int J Basic Clin Pharmacol 2016;5:2438-43. doi: 10.18203/2319-2003. ijbcp20164101

Eluwa GI, Badru T, Agu KA, Akpoigbe KJ, Chabikuli O, Hamelmann C. Adverse drug reactions to antiretroviral therapy (ARVs): Incidence, type and risk factors in Nigeria. BMC Clin Pharmacol 2012;12:7. doi: 10.1186/1472-6904-12-7, PMID 22369677

Tenofovir Based Highly Active Antiretroviral Therapy is Associated with Superior CD4 T Cells Repopulation Compared to Zidovudine Based HAART in HIV 1 Infected Adults. Available from: https://www.hindawi. com/journals/ijcd/2018/3702740. [Last accessed on 2021 Jul 16].

Hemasri M, Sudhapoornima P, Sowmya CH, Ramya S, Avinash I, Kumar B. Safety and effectiveness of anti-retroviral drug regimen ZLN and TLE in tertiary care teaching hospital: A prospective observational study. IOSR JPBS 2016;11:88-96.

Evaluation of Adverse Drug Reaction Profile of Drugs Used as First Line Antiretroviral Therapy. Available from: https://www.hindawi.com/ journals/ipid/2018/80/95609. [Last accessed on 2021 Jun 08].